Atlas Trials

A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer

Clinical trial NCT03348527 · COMPLETED

Trial details

NCT number
NCT03348527
Sponsor
Lidds AB
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2017-05-12
Primary completion
2020-10-30
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.